Direct sales USA_1080
Resuming of direct sales in the U.S. market starting in Q4 2025
The global leader for SEEG depth electrodes, resuming direct sales in the U.S. following the contractual end of its distribution partnership with NeuroPace.
Faiçal Isbaine, DIXI medical
Meeting Faiçal Isbaine, our new Director Clinical Development
Faiçal Isbaine joined DIXI medical as our new Director Clinical Development
new scientific direction within DIXI medical
Creation of a scientific direction and appointment of John Gale as Chief Scientific Officer
We are pleased to announce the creation of a new scientific direction within DIXI medical...
DIXI medical. A worldwide commitment to SEEG education
A worldwide commitment to SEEG education
At DIXI medical, we are proud to support the continuing and specialized education of healthcare professionals in the field of epilepsy.
DIXI medical, VP Reserach and Development
Welcome to our new VP Research & Development
We are delighted to announce the arrival of our new VP Research & Development, Pierre Fridez.
DIXI medical, Health Canada approves thermocoagulation procedures
Health Canada approves thermocoagulation procedures
We are thrilled to announce that Health Canada has approved thermocoagulation procedures as an extension of the intended use of our depth electrodes.
DIXI medical. Unveiling the Mysteries of single-neuron recordings
Webinar: Unveiling the Mysteries of single-neuron recordings
John Gale, renowned Neurophysiologist, Vice President of DIXI NeuroLab, launches an insightful 6-Episode webinar on the inner workings of the human brain and microelectrode recordings.